Carladenise Armbrister Edwards - 22 Sep 2022 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Director
Signature
/s/ Jamie L. Reynoso, Attorney-in-Fact for Carladenise Armbrister Edwards
Issuer symbol
CLOV
Transactions as of
22 Sep 2022
Net transactions value
$0
Form type
4
Filing time
26 Sep 2022, 18:02:07 UTC
Previous filing
26 Jul 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +20,271 +230% $0.000000 29,076 22 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSU"). One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date.

Remarks:

Exhibit List 24.1-Power of Attorney